Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.

Doctors who treat this condition

Edit search filters
close

Narrow your search

  1. Find a doctor whose last name begins with the letter A
  2. Find a doctor whose last name begins with the letter B
  3. Find a doctor whose last name begins with the letter C
  4. Find a doctor whose last name begins with the letter D
  5. There are no doctors whose last name begins with the letter E
  6. Find a doctor whose last name begins with the letter F
  7. There are no doctors whose last name begins with the letter G
  8. Find a doctor whose last name begins with the letter H
  9. Find a doctor whose last name begins with the letter I
  10. Find a doctor whose last name begins with the letter J
  11. Find a doctor whose last name begins with the letter K
  12. active Find a doctor whose last name begins with the letter L
  13. Find a doctor whose last name begins with the letter M
  14. There are no doctors whose last name begins with the letter N
  15. There are no doctors whose last name begins with the letter O
  16. Find a doctor whose last name begins with the letter P
  17. There are no doctors whose last name begins with the letter Q
  18. Find a doctor whose last name begins with the letter R
  19. Find a doctor whose last name begins with the letter S
  20. Find a doctor whose last name begins with the letter T
  21. There are no doctors whose last name begins with the letter U
  22. Find a doctor whose last name begins with the letter V
  23. Find a doctor whose last name begins with the letter W
  24. Find a doctor whose last name begins with the letter X
  25. Find a doctor whose last name begins with the letter Y
  26. Find a doctor whose last name begins with the letter Z
Reset all filters

Displaying 1-2 out of 2 doctors available

Last Name Initial: L

  1. Michael D. Leise, M.D.

    Michael D. Leise, M.D.

    1. Transplant Hepatologist
    1. Rochester, MN
    Areas of focus:

    Colonoscopy, Upper endoscopy, Cirrhosis, Hepatic encephalopathy, Liver problems, Esophageal varices, Hepatitis C, Prima...ry sclerosing cholangitis, Hepatitis B, Cholangiocarcinoma, Portal hypertension, Hemochromatosis, Alcoholic hepatitis, Autoimmune hepatitis, Hepatocellular carcinoma, Wilson's disease, Hepatopulmonary syndrome, Primary biliary cholangitis, Nonalcoholic fatty liver disease, Hereditary hemorrhagic telangiectasia, Portopulmonary hypertension

  2. Nicole M. Loo, M.D.

    Nicole M. Loo, M.D.

    1. Internist
    2. Transplant Hepatologist
    1. Jacksonville, FL
    Areas of focus:

    Liver transplant, Post-transplant long-term care, Pre-transplant evaluation, Cirrhosis, Liver problems, Hepatitis C, Pr...imary sclerosing cholangitis, Hepatitis B, Cholangiocarcinoma, Liver cancer, Alcoholic hepatitis, Acute liver failure, Autoimmune hepatitis, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary cholangitis, Nonalcoholic fatty liver disease, Fatty liver disease, Liver mass

Research

Researchers discuss a bile duct cancer project Bile duct cancer researchers

Doctors and scientists work together to develop new options for people with bile duct cancer.

Researchers at Mayo Clinic are studying new ways to diagnose and treat cholangiocarcinoma. This research is conducted as part of the Gastrointestinal Cancer Program and in coordination with Mayo Clinic Comprehensive Cancer Center.

Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute (NCI) and is an NCI-designated comprehensive cancer center — recognition for an institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.

Areas of research include:

  • Studying the association of aspirin and statin medications with a reduced risk of cholangiocarcinoma
  • Investigating the molecular genetics of a tumor and identifying biomarkers, which may aid in early diagnosis or lead to new targeted therapies
  • Doing clinical trials for new targeted therapies, which is possible because of Mayo Clinic's high patient volume for primary sclerosing cholangitis and bile duct cancer
  • Improving safety of procedures and developing new ones
  • Proving that the biomarker CA 19-9 is useful for staging cholangiocarcinoma and understanding the prognosis for people with the disease

Publications

See a list of publications about cholangiocarcinoma by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

Research Profiles

Edit search filters
close

Narrow your search

View all physicians • Florida

Cholangiocarcinoma (bile duct cancer) care at Mayo Clinic

June 06, 2023